Detalles de la búsqueda
1.
Mortality and cause of death in persons with chronic hepatitis B virus infection versus healthy persons from the general population in Denmark.
J Viral Hepat
; 29(9): 727-736, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35633092
2.
Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non-target sites, for DAA-based treatment and retreatment outcome.
J Viral Hepat
; 28(2): 302-316, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33131178
3.
Inferior cure rate in pilot study of 4-week glecaprevir/pibrentasvir treatment with or without ribavirin of chronic hepatitis C.
Liver Int
; 41(11): 2601-2610, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34154034
4.
Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation.
Scand J Gastroenterol
; 53(7): 849-856, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29720023
5.
Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland--using spontaneous resolvers as the benchmark comparator.
Hepatology
; 63(5): 1506-16, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26773546
6.
Declining prevalence of hepatitis E antibodies among Danish blood donors.
Transfusion
; 55(7): 1662-7, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25819381
7.
Depressive symptoms are frequent among drug users, but not associated with hepatitis C infection.
Scand J Infect Dis
; 46(8): 566-72, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24934987
8.
Four weeks of ledipasvir/sofosbuvir and ribavirin with or without pegylated interferon for chronic hepatitis C in non-cirrhotic people who inject drugs. A randomized trial.
J Hepatol
; 68(4): 840-842, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29223370
9.
Liver stiffness and 30-day mortality in a cohort of patients admitted to hospital.
Eur J Clin Invest
; 42(2): 146-52, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21793821
10.
Four Weeks Treatment with Glecaprevir/Pibrentasvir + Ribavirin-A Randomized Controlled Clinical Trial.
Viruses
; 14(3)2022 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35337021
11.
Incidence of Hepatocellular Carcinoma and Decompensated Liver Cirrhosis and Prognostic Accuracy of the PAGE-B HCC Risk Score in a Low Endemic Hepatitis B Virus Infected Population.
J Hepatocell Carcinoma
; 9: 1093-1104, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36281336
12.
Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: a Danish nationwide cohort study.
BMC Infect Dis
; 11: 177, 2011 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-21693019
13.
Characterization of a Novel Hepatitis C Virus Genotype 1 Subtype from a Patient Failing 4 Weeks of Glecaprevir-Pibrentasvir Treatment.
Microbiol Resour Announc
; 10(41): e0075521, 2021 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34647796
14.
Reply: To PMID 24519039.
Hepatology
; 60(6): 2130-1, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24591101
15.
Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark.
Clin Infect Dis
; 47(8): 1026-31, 2008 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18781880
16.
Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: a clinical randomized study.
Eur J Gastroenterol Hepatol
; 30(10): 1177-1186, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29994874
17.
Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study.
Clin Infect Dis
; 42(10): 1481-7, 2006 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16619163
18.
Dried blood spots, valid screening for viral hepatitis and human immunodeficiency virus in real-life.
World J Gastroenterol
; 22(33): 7604-12, 2016 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27672281
19.
Liver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective study.
PLoS One
; 9(11): e111912, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25369038
20.
Nationwide experience of treatment with protease inhibitors in chronic hepatitis C patients in Denmark: identification of viral resistance mutations.
PLoS One
; 9(12): e113034, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25438153